<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Bone and joint infections guidelines MeG-CLS-050</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="bone-and-joint-infections">Bone and Joint infections</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>Bone and joint infections are serious conditions requiring prompt diagnosis and treatment to prevent disability and mortality. They consist of osteomyelitis (OM) and septic arthritis (SA). Both are bacterial infections that occur by a hematogenous spread from other parts of the body. They may result in sepsis and bone loss. These infections frequently occur in the lower limbs but can occur in the upper limbs and vertebrae.</p>
<p>The most common causative organism is <em>Staphylococcus aureus</em> in all ages. <em>Hemophilus influenza</em> is also common in children aged less than 5 years. In sexually active adults and adolescents, <em>Neisseria gonorrhoea</em> could be suspected. Bone and joint infections in sickle cell disease patients may be caused by <em>Salmonella spp</em></p>
<p>Osteomyelitis is an infection of the bone that may be acute or chronic. Acute osteomyelitis is a medical emergency requiring a long duration of treatment with intravenous antibiotics. A chronic OM is managed by the orthopaedic surgeons and its presentation is insidious in onset, occurring over weeks and with draining sinuses on the skin.</p>
<p>Septic arthritis is an acute bacterial joint infection and an orthopedic emergency requiring arthrocentesis and intravenous antibiotics to prevent joint deformity and disability.</p>
<h2 id="target-users">Target users</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
</ul>
<h2 id="target-area-of-use">Target area of use </h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Outpatients</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
</ul>
<h2 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h2>
<p>This guideline outlines the diagnosis and management of bone and joint infections.</p>
<h2 id="limitations">Limitations</h2>
<p>Patients with suspected septic arthritis must be referred to the orthopaedic surgeons as soon as possible.</p>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<p>The symptoms and signs of OM and SA are of an acute onset (usually within days) and include:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Fever (some babies may be apyrexial)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Swelling of the limb or joint</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Limping or refusal to use affected limb</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Movement restriction at the joint(s) – OA</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Malaise</p>
</div></li>
</ul>
<p>There may be no preceding history of trauma or penetrative injury to the affected limb.</p>
<h2 id="examination-findings">Examination findings:</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Fever</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Tender joint or limb swelling, non-pitting with differential warmth</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Joint movement restriction</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Painful gait</p>
</div></li>
</ul>
<h2 id="differential-diagnoses">Differential diagnoses :</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Acute OM</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Traumatic or stress fracture</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Cellulitis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Pyomyositis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Septicaemia (newborns)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Thrombophlebitis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Sickle cell infarction</p>
</div></li>
</ul></li>
<li><div data-custom-style="List Paragraph">
<p>SA</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Viral arthritis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Reactive arthritis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Juvenile idiopathic arthritis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Tuberculosis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Slipped capital femoral epiphysis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Vaso-occlusive crisis in sickle cell anaemia</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Arthralgia</p>
</div></li>
</ul></li>
</ul>
<h2 id="investigations">Investigations</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>ESR</p>
</div></li>
</ul>
<ul>
<li><div data-custom-style="List Paragraph">
<p>FBC</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Blood culture</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>X-ray to rule out fracture, chronic OM</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>MRI for Acute OM</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Joint aspiration for microscopy, culture and sensitivity – should be done before commencement of empirical antibiotic therapy</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>US scan of the joints may be done in children</p>
</div></li>
</ul>
<h2 id="management">Management</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Empirical antibiotic therapy is based on the commonest organisms responsible for infections – <em>Staph. aureus</em> in adults and children over 5 years and <em>Haemophilus influenza</em> for children aged under 5 years.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>For SA, antibiotic therapy is given for 2-3 weeks. If patient improves on IV antibiotics after 4-6 days, oral antibiotics can be used and continued until the end of 3 weeks.</p>
</div></li>
</ul>
<ul>
<li><div data-custom-style="List Paragraph">
<p>For OM, parenteral antibiotics should be given for at least 2 weeks before continuing on oral therapy. Duration of therapy for children is between 3-4 weeks and for adults 4–6 weeks.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Empirical antibiotic therapy should be changed if antibiotic sensitivity results are different from current therapy.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Serial arthrocentesis, arthroscopy or arthrotomy may be needed in SA.</p>
</div></li>
</ul>
<p><strong>Empirical antibiotic therapy</strong></p>
<table>
<thead>
<tr class="header">
<th><strong>Age</strong></th>
<th><strong>OM</strong></th>
<th><strong>SA</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Children under 5 years</td>
<td>IV Cloxacillin 25-50 mg/kg QDS <em>plus</em> Ceftriaxone 50-75 mg/kg OD for 4 -6 days <em>followed by</em> oral Amoxicillin 15 mg/kg + clavulanic acid (maximum 500 mg) orally every 8 hours to complete the treatment course.</td>
<td>IV Cloxacillin 25-50 mg/kg QDS <em>plus</em> Ceftriaxone 50-75 mg /kg OD for 4-6 days <em>followed by</em> oral Cloxacillin 12.5 mg/kg QDS for the duration of treatment.</td>
</tr>
<tr class="even">
<td><em>Children aged 5 years and above</em></td>
<td><p>IV Cloxacillin 25–50 mg/kg (maximum 2 g) QDS for 4-6 days (or until clinical improvement occurs), followed by cloxacillin 25 mg/kg (maximum 500 mg) orally every 6 hours to complete the treatment course</p>
<p>OR</p>
<p>IV Ceftriaxone 50–75 mg/kg (maximum 1 g) OD for 4-6 days (or until clinical improvement occurs), followed by oral Cloxacillin 25 mg/kg (maximum 500 mg) orally QDS to complete the treatment course.</p></td>
<td>IV Cloxacillin 25-50 mg/kg QDS plus IV Ceftriaxone 25-50 mg/kg OD</td>
</tr>
<tr class="odd">
<td><em>Adults</em></td>
<td>IV Cloxacillin 2 g QDS for at least the initial 14 days, but preferably the entire treatment course of 4-6 weeks (if the duration of parenteral therapy is less than 4-6 weeks, the treatment course should be completed with cloxacillin 1 g orally QDS)</td>
<td>IV Cloxacillin 2 g QDS plus IV Ceftriaxone 1-2 g OD</td>
</tr>
</tbody>
</table>
<ul>
<li><div data-custom-style="List Paragraph">
<p>On suspicion of septic arthritis, the orthopaedic surgeon at the teaching hospital should be informed and patient should be referred.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>All patients with bone and joint infections should be informed of the seriousness of the condition and the need for adherence to the long course of antibiotic therapy.</p>
</div></li>
</ul>
<p><strong>Key Issues for Nursing care</strong></p>
<p>Patients suspected of having bone or joint infections should see a doctor immediately, as this is an emergency.</p>
<h2 id="references">References</h2>
<p>Coakley G, Mathews C, Field M, Jones A, Kingsley G, Walker D, Phillips M, Bradish C, McLachlan A, Mohammed R, Weston V. BSR &amp; BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology. 2006 Jul 6;45(8):1039-41.</p>
<p>Saavedra-Lozano J, Falup-Pecurariu O, Faust SN, Girschick H, Hartwig N, Kaplan S, Lorrot M, Mantadakis E, Peltola H, Rojo P, Zaoutis T. Bone and joint infections. The Pediatric infectious disease journal. 2017 Aug 1;36(8):788-99</p>
<p>Korean Orthopaedic Association. Clinical guidelines for the antimicrobial treatment of bone and joint infections in Korea. Infection &amp; chemotherapy. 2014 Jun 1;46(2):125-38.</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Orighomisan Agboghoroma</th>
<th>Date: 13 November 2018</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Karen Forrest</td>
<td>Date: 16 November 2018</td>
</tr>
<tr class="even">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="odd">
<td>1.0</td>
<td>New document</td>
<td>31 January 2021</td>
</tr>
<tr class="even">
<td>1.1</td>
<td>Executive summary added</td>
<td>31 January 2021</td>
</tr>
<tr class="odd">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
